Borax Affects Cellular Viability by Inducing ER Stress in Hepatocellular Carcinoma Cells by Targeting SLC12A5

Overview

Journal J Cell Mol Med

Specialties Cell Biology
Molecular Biology

Date 2024 May 23

PMID 38780503

Authors

Ceyhan Hacioglu

Didem Oral

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma (HCC) presents a persistent challenge to conventional therapeutic approaches. SLC12A5 is implicated in an oncogenic capacity and facilitates the progression of cancer. The objective of this investigation is to scrutinize the inhibitory effects of borax on endoplasmic reticulum (ER)-stress and apoptosis mediated by SLC12A5 in HepG2 cells. Initially, we evaluated the cytotoxic impact of borax on both HL-7702 and HepG2 cell lines. Subsequently, the effects of borax on cellular morphology and the cell cycle of these lines were examined. Following this, we explored the impact of borax treatment on the mRNA and protein expression levels of SLC12A5, C/EBP homologous protein (CHOP), glucose-regulated protein-78 (GRP78), activating transcription factor-6 (ATF6), caspase-3 (CASP3), and cytochrome c (CYC) in these cellular populations. The determined IC50 value of borax for HL-7702 cells was 40.8 mM, whereas for HepG2 cells, this value was 22.6 mM. The concentrations of IC50 (22.6 mM) and IC75 (45.7 mM) of borax in HepG2 cells did not manifest morphological aberrations in HL-7702 cells. Conversely, these concentrations in HepG2 cells induced observable morphological and nuclear abnormalities, resulting in cell cycle arrest in the G1/G0 phase. Additionally, the levels of SLC12A5, ATF6, CHOP, GRP78, CASP3, and CYC were elevated in HepG2 cells in comparison to HL-7702 cells. Moreover, SLC12A5 levels decreased following borax treatment in HepG2 cells, whereas ATF6, CHOP, GRP78, CASP3, and CYC levels exhibited a significant increase. In conclusion, our data highlight the potential therapeutic effects of borax through the regulation of ER stress in HCC by targeting SLC12A5.

Citing Articles

Borax affects cellular viability by inducing ER stress in hepatocellular carcinoma cells by targeting SLC12A5.

Hacioglu C, Oral D J Cell Mol Med. 2024; 28(10):e18380.

PMID: 38780503 PMC: 11114215. DOI: 10.1111/jcmm.18380.

References

Lee Y, Tan Y, Oon C . Molecular targeted therapy: Treating cancer with specificity. Eur J Pharmacol. 2018; 834:188-196. DOI: 10.1016/j.ejphar.2018.07.034. View

Kahraman E, Goker E . Boric acid exert anti-cancer effect in poorly differentiated hepatocellular carcinoma cells via inhibition of AKT signaling pathway. J Trace Elem Med Biol. 2022; 73:127043. DOI: 10.1016/j.jtemb.2022.127043. View

Henderson K, Kobylewski S, Yamada K, Eckhert C . Boric acid induces cytoplasmic stress granule formation, eIF2α phosphorylation, and ATF4 in prostate DU-145 cells. Biometals. 2014; 28(1):133-41. PMC: 4300416. DOI: 10.1007/s10534-014-9809-5. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Reich S, Nguyen C, Has C, Steltgens S, Soni H, Coman C . A multi-omics analysis reveals the unfolded protein response regulon and stress-induced resistance to folate-based antimetabolites. Nat Commun. 2020; 11(1):2936. PMC: 7287054. DOI: 10.1038/s41467-020-16747-y. View

Huang C, Lai Z, Hsu T, Chou F, Liu H, Chuang Y . Boron Neutron Capture Therapy Eliminates Radioresistant Liver Cancer Cells by Targeting DNA Damage and Repair Responses. J Hepatocell Carcinoma. 2023; 9:1385-1401. PMC: 9807134. DOI: 10.2147/JHC.S383959. View

Pavlovic N, Heindryckx F . Targeting ER stress in the hepatic tumor microenvironment. FEBS J. 2021; 289(22):7163-7176. DOI: 10.1111/febs.16145. View

Di Conza G, Ho P . ER Stress Responses: An Emerging Modulator for Innate Immunity. Cells. 2020; 9(3). PMC: 7140669. DOI: 10.3390/cells9030695. View

Hung Y, Lin Y, Lin Y, Shih G, Liao J, Chen K . Suitability of boric acid as a boron drug for boron neutron capture therapy for hepatoma. Appl Radiat Isot. 2020; 164:109254. DOI: 10.1016/j.apradiso.2020.109254. View

10.

Yang G, He W, Tan J, Yang Z, Fan R, Ma N . Overexpression of SLC12A5 is associated with tumor progression and poor survival in ovarian carcinoma. Int J Gynecol Cancer. 2019; 29(8):1280-1284. DOI: 10.1136/ijgc-2019-000229. View

11.

Tombuloglu A, Copoglu H, Aydin-Son Y, Guray N . In vitro effects of boric acid on human liver hepatoma cell line (HepG2) at the half-maximal inhibitory concentration. J Trace Elem Med Biol. 2020; 62:126573. DOI: 10.1016/j.jtemb.2020.126573. View

12.

Fu X, Cui J, Meng X, Jiang P, Zheng Q, Zhao W . Endoplasmic reticulum stress, cell death and tumor: Association between endoplasmic reticulum stress and the apoptosis pathway in tumors (Review). Oncol Rep. 2021; 45(3):801-808. PMC: 7859917. DOI: 10.3892/or.2021.7933. View

13.

Tong Q, Qin W, Li Z, Liu C, Wang Z, Chu Y . SLC12A5 promotes hepatocellular carcinoma growth and ferroptosis resistance by inducing ER stress and cystine transport changes. Cancer Med. 2023; 12(7):8526-8541. PMC: 10134347. DOI: 10.1002/cam4.5605. View

14.

Kim C, Kim B . Anti-Cancer Natural Products and Their Bioactive Compounds Inducing ER Stress-Mediated Apoptosis: A Review. Nutrients. 2018; 10(8). PMC: 6115829. DOI: 10.3390/nu10081021. View

15.

Wu L, Wei Y, Zhou W, Zhang Y, Chen Q, Liu M . Gene expression alterations of human liver cancer cells following borax exposure. Oncol Rep. 2019; 42(1):115-130. PMC: 6549072. DOI: 10.3892/or.2019.7169. View

16.

Abdelnour S, Abd El-Hack M, Swelum A, Perillo A, Losacco C . The vital roles of boron in animal health and production: A comprehensive review. J Trace Elem Med Biol. 2018; 50:296-304. DOI: 10.1016/j.jtemb.2018.07.018. View

17.

Wang L, Zhang Q, Wu P, Xiang W, Xie D, Wang N . SLC12A5 interacts and enhances SOX18 activity to promote bladder urothelial carcinoma progression via upregulating MMP7. Cancer Sci. 2020; 111(7):2349-2360. PMC: 7385366. DOI: 10.1111/cas.14502. View

18.

Zhang L, Zhang X . Roles of GRP78 in physiology and cancer. J Cell Biochem. 2010; 110(6):1299-305. DOI: 10.1002/jcb.22679. View

19.

Moore Y, Deeb T, Chadchankar H, Brandon N, Moss S . Potentiating KCC2 activity is sufficient to limit the onset and severity of seizures. Proc Natl Acad Sci U S A. 2018; 115(40):10166-10171. PMC: 6176565. DOI: 10.1073/pnas.1810134115. View

20.

Pavlova N, Zhu J, Thompson C . The hallmarks of cancer metabolism: Still emerging. Cell Metab. 2022; 34(3):355-377. PMC: 8891094. DOI: 10.1016/j.cmet.2022.01.007. View